SAN DIEGO, June 19, 2014 (GLOBE NEWSWIRE) -- Senté Inc., a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycoproteins, announced today that the European Patent Office has granted a patent for use of a low molecular weight heparan sulfate ("HS") for cosmetic products. Sente holds exclusive rights to the relevant patent estate held by Laboratori Derivati Organici SpA ("LDO") of Milan, Italy. HS is the most biologically active glycoprotein that resides in all layers of human skin and is the scientific base to Senté's proprietary Dermal Repair Cream. The coverage under this newly granted patent includes the Process for the Purification of HS and Use Thereof in Cosmetological and Dermatological Preparations. The HS patent estate, exclusively licensed to Senté, has produced patents in the United States and Europe and has strengthened Sente's ability to distribute its innovative skin care products worldwide.
"We are pleased to expand our intellectual property portfolio around the low molecular weight heparan sulfate technology with a new patent in a major market like Europe," commented Michael York, President and Chief Executive Officer of Senté, Inc. "With these key patents in place, we are well positioned to broaden distribution of Senté's medical grade skin care products in strategic markets around the world."
Senté Dermal Repair Cream, Senté's first physician dispensed dermatological product, was launched in 2013 and helps the body replenish the essential skin building blocks that are lost with aging and UV exposure. It features a proprietary formulation of low molecular weight heparan sulfate, or HS, which is the most biologically active of the glycoproteins that reside in all layers of human skin. This biologically active low molecular weight HS analogue used in Senté Dermal Repair Cream has been shown to increase skin hydration, gradually brighten the appearance of pigmented lesions and soothe irritated skin.
About Senté, Inc.
Senté, Inc. is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skin care products. Senté is a recognized leader in the development of innovative and targeted medical skincare products based on glycoproteins. Senté recently launched its first physician dispensed dermatological product, Senté Dermal Repair Cream, which is currently the only aesthetic product utilizing low molecular weight heparan sulfate on the market today. HS is the most biologically active of the glycoproteins that reside naturally in human skin, and is responsible for regulating a wide variety of biological activities within the body. The biologically active glycoproteins used in Senté Dermal Repair Cream help increase skin hydration, gradually lighten the appearance of pigmented lesions and soothe irritated skin. Founded in 2007 and based in San Diego, California, further information may be found at http://sentelabs.com/. Sente products are available through our exclusive network of physicians, medically supervised spas and through Sentelabs.com.